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STUDY QUESTION: Does pain or volume of used contrast medium impact the effectiveness of oil-based contrast during hysterosalpingog-
raphy (HSG)?
SUMMARY ANSWER: In women who report moderate to severe pain during HSG, the use of oil-based contrast resulted in more ongoing
pregnancies compared to the use of water-based contrast, whereas in women who reported mild or no pain, no difference in ongoing
pregnancies was found.
WHAT IS KNOWN ALREADY: We recently showed that in infertile women undergoing HSG, the use of oil-based contrast results in
more ongoing pregnancies within 6 months as compared to the use of water-based contrast. However, the underlying mechanism of this
fertility-enhancing effect remains unclear.
STUDY DESIGN, SIZE, DURATION: We performed a post-hoc analysis of the H2Oil study, a multicentre randomised controlled trial
(RCT) evaluating the therapeutic effect of oil- and water-based contrast at HSG. Here, we evaluated the impact of pain experienced at HSG
and volume of used contrast media during HSG on ongoing pregnancy.
PARTICIPANTS/MATERIALS, SETTING, METHODS: In a subset of 400 participating women, pain during HSG by means of the Visual
Analogue Scale (VAS) (range: 0.0–10.0 cm) was reported, while in 512 women, we registered the volume of used contrast (in millilitres). We
used logistic regression analyses to assess whether pain and volume of used contrast media modified the effect of oil-based contrast on ongoing
pregnancy rates. Data were analysed according to intention-to-treat principle.
MAIN RESULTS AND THE ROLE OF CHANCE: In 400 women in whom pain scores were reported, the overall median pain score was
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interaction between pain (VAS ≤5 versus VAS ≥6) and the primary outcome ongoing pregnancy (P-value 0.047). In women experiencing pain
(VAS ≥6), HSG with oil-based contrast resulted in better 6-month ongoing pregnancy rates compared to HSG with water-based contrast
(49.4% versus 29.6%; RR 1.7; 95% CI, 1.1–2.5), while in women with a pain score ≤5, 6-month ongoing pregnancy rates were not significantly
different between the use of oil- (28.8%) versus water-based contrast (29.2%) (RR 0.99; 95% CI, 0.66–1.5). In the 512 women in whom we
recorded contrast, median volume was 9.0 ml (IQR 5.7–15.0) in the oil group versus 8.0 ml (IQR 5.9–13.0) in the water group, respectively
(P-value 0.72). Volume of used contrast was not found to modify the effect of oil-based contrast on ongoing pregnancy (P-value for interaction
0.23).
LIMITATIONS, REASONS FOR CAUTION: This was a post-hoc analysis that should be considered as hypothesis generating. The RCT
was restricted to infertile ovulatory women, younger than 39 years of age and with a low risk for tubal pathology. Therefore, our results should
not be generalised to infertile women who do not share these features.
WIDER IMPLICATIONS OF THE FINDINGS: The underlying mechanism of the fertility-enhancing effect induced by HSG with the use
of oil-based contrast remains unclear. However, these findings suggest a possible mechanistic pathway, that is increasing intrauterine pressure
occurring prior to dislodging pregnancy hindering debris or mucus plugs from the proximal part of otherwise normal fallopian tubes. This
information might help in the search of the underlying fertility-enhancing mechanism found by using oil-based contrast during HSG.
STUDY FUNDING/COMPETING INTEREST(S): The original H2Oil RCT was an investigator-initiated study that was funded by the
two academic institutions (AMC and VUmc) of the Amsterdam UMC. The funders had no role in study design, collection, analysis and
interpretation of the data. K.D. reports consultancy for Guerbet. H.V. reports consultancy fees from Ferring. C.B.L. reports speakers’ fees
from Ferring and research grants from Ferring, Merck and Guerbet. V.M. reports receiving travel and speakers fees as well as research grants
from Guerbet. B.W.M. is supported by an NHMRC Practitioner Fellowship (GNT1082548). B.W.M. reports consultancy for ObsEva, Merck
KGaA and Guerbet and travel and research grants from Merck KGaA and Guerbet. The other authors do not report conflict of interests.
TRIAL REGISTRATION NUMBER: The H2Oil study was registered at the Netherlands Trial Registry (NTR 3270).
TRIAL REGISTRATION DATE: 1 February 2012.
DATE OF FIRST PATIENT’S ENROLMENT: 3 February 2012.
Key words: hysterosalpingography / tubal flushing / oil-based contrast / pain score / ongoing pregnancy rate / female infertility
Introduction
Assessment of the fallopian tubes is an important part of the fertility
work-up. Hysterosalpingography (HSG) is the oldest tubal patency
test and is still commonly applied in many countries. While HSG
was introduced as a diagnostic test, it was, more than 50 years ago,
also suggested to directly lead to an increased pregnancy rate (King
and Herring, 1949; Weir and Weir, 1951). However, high-quality
evidence supporting this fertility-enhancing effect was lacking. Also, it
was unclear whether the type of contrast medium used affects this
potential therapeutic effect (Watson et al., 1994; Mohiyiddeen et al.,
2015).
In 2017, we compared oil- and water-based contrast in a large mul-
ticentre randomised controlled trial (RCT) performed in the Nether-
lands under the acronym the H2Oil study (Dreyer et al., 2017). A total
of 1119 women were randomised and allocated to tubal flushing at
HSG with the use of oil-based contrast medium (n = 557) or water-
based contrast medium (n = 562). The 6-month ongoing pregnancy
rates were higher after tubal flushing at HSG with oil-based contrast
(39.7%) compared to the use of water-based contrast (29.1%) (relative
risk (RR), 1.37; 95% confidence interval (CI), 1.16–1.61; P < 0.001).
Recent updated systematic reviews and meta-analyses have confirmed
these findings (Fang et al., 2018; Wang et al., 2019).
Several potential theories have been proposed to elucidate the
fertility-enhancing mechanism of tubal flushing, especially with oil-
based contrast, including a mechanistic pathway dislodging non-
occlusive but pregnancy-hindering debris or mucus plugs from
otherwise undamaged fallopian tubes (Gillespie, 1965; Kerin et al.,

































































immunobiological effects on the endometrium (Yun and Lee, 2004;
Johnson, 2014) and/or in the peritoneal cavity (Sawatari et al., 1993;
Mikulska et al., 1994; Izumi et al., 2017).
In the H2Oil study, we measured in a subset of women for pain
experienced during HSG and registered the used volume of contrast.
While both experienced pain and used contrast volume were compara-
ble between the two groups, we did not study whether the treatment
effect of oil-based contrast versus water-based contrast on ongoing
pregnancy was associated with the pain that women experienced
and/or the volume of contrast that was used. Moreover, previous
oil-water studies have not addressed this (de Boer et al., 1988; Ras-
mussen et al., 1991). Two studies reported on volume of used contrast
medium and pain scores, but did not relate them to the treatment effect
(Alper et al., 1986; Lindequist et al., 1994).
Here, we investigate whether pain and used volume of contrast
medium during HSG were associated with the treatment effect of
oil-based contrast on ongoing pregnancy in the H2Oil study.
Materials and Methods
Study design and patients
This is a post-hoc data analysis of our multicentre RCT, the H2Oil
study (NTR 3270) comparing ongoing pregnancy rates after the use of
oil-based contrast versus water-based contrast in infertile women
undergoing HSG. The study was approved by the Institutional Review
Board of the Amsterdam UMC, University of Amsterdam, the Nether-
lands. The original study has been described in detail previously (Dreyer
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had been trying to conceive for at least 1 year, were between 18 and
39 years of age, had spontaneous ovulatory cycles, and were at low risk
for tubal pathology and if the male partner did not have severe male
infertility, defined as a total motile sperm count (TMSC) after sperm
wash of <3 million sperm per millilitre (ml).
After written informed consent, women were randomly assigned
in a 1:1 ratio to the use of oil-based contrast (Lipiodol Ultra-Fluid
®
,
Guerbet) (the oil group) or water-based contrast (Telebrix Hystero
®
,
Guerbet) (the water group) during HSG. Telebrix Hystero
®
was the
most commonly used and registered water-based contrast for HSG
in the Netherlands. Lipiodol Ultra-Fluid
®
was the only available oil-
based contrast in the Netherlands. Table I shows the chemical and
physical characteristics of the two contrast media. HSG was performed
according to local protocols of the participating hospitals by a gynae-
cologist. The use of pain medication depended on local protocols (i.e.
paracetamol, ibuprofen, naproxen or diclofenac). Contrast medium
could be infused into the uterus with the use of a cervical vacuum
cup, a metal cannula (hysterophore) or a balloon catheter, depending
on preference and/or experience of the performing gynaecologist.
Usually, 5–10 ml of contrast medium was infused and four to six
radiographs, obtained to evaluate patency of both fallopian tubes, were
examined by a gynaecologist and/or radiologist.
Couples were managed based on their prognosis for natural con-
ception. In case of a prognosis for natural conception resulting in a
life birth ≥30% in 12 months, couples were counselled for expectant
management. When the prognosis for natural conception was <30%,
treatment with intrauterine insemination was performed (Hunault
et al., 2005). In case of bilateral tubal occlusion on HSG, confirmed at
laparoscopy, or when the male partner had very poor semen quality
at repeated semen analysis, couples were advised to start in vitro
fertilisation or intracytoplasmic sperm injection treatment. The primary
outcome was ongoing pregnancy, defined as a viable pregnancy at 12-
week ultrasound, with the first day of the last menstrual cycle before












































































In seven clinics (two academic and five teaching hospitals), pain
scores were recorded immediately after completion of the HSG pro-
cedure by means of the Visual-Analogue Scale (VAS) for pain (scores
range from 0.0 to 10.0 cm, with higher scores indicating more severe
pain), which is a valid and reliable pain scale (Karcioglu et al., 2018). As
VAS scores were rounded to integers before data entry in some, we
decided to round all VAS scores to integers for statistical analyses. In
16 clinics (three academic, ten teaching and three general hospitals),
the volume of used contrast was recorded. Volume was measured
by subtracting the remaining volume of contrast in ml after HSG was
completed from the volume of contrast in ml at the beginning of the
procedure, based on 10 ml per ampule. The subsets of women in which
pain scores and volume of used contrast were measured and reported
were randomly selected.
Statistical analysis
In this post-hoc analysis, we evaluated whether pain and volume of
used contrast medium during HSG could modify the treatment effect
of type of contrast (oil versus water) on 6-month ongoing pregnancy
rates. Effect-modification was tested separately for pain and volume
of contrast using logistic regression models with ongoing pregnancy
as the dependent variable and type of contrast (oil versus water), the
candidate effect modifier (pain or contrast volume) and their two-way
interaction as independent variables. In case of a statistically significant
two-way interaction, the treatment effect of oil-based contrast was
subsequently quantified in the two separate strata defined by the effect
modifier by calculating strata-specific Relative Risks (RR) for ongoing
pregnancy. Pain score and volume were dichotomised using a median
split due to lack of a clinical cut-off point. All analyses of this study were
exploratory post-hoc analyses and performed based on the intention-
to-treat analysis. We used SPSS version 22.0 (IBM SPSS Statistics for
Windows, 2016) for analysis.






Iodine amount (mg I/ml) 480 250
Viscosity
- At 15◦C or 20◦C (mPa·s) 70 220
- At 37◦C (mPa·s) 25 100
Osmolality (mOsm/kg) NAa 2260
Density
- At 15◦C or 20◦C (g/cm3) 1.28b 1.33c
- At 37◦C (g/cm3) Unknownd 1.32
Ingredients Ethyl esters of fatty acids of poppy seeds oil Ioxitalamate acid meglumine





aNo osmolality for Lipiodol since it is an oil.
bDensity at 15◦C.
cDensity at 20◦C.
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Results
Between February 2012 and October 2014, a total of 1119 women
were randomised for the use of oil-based contrast (n = 557) or water-
based contrast (n = 562) during HSG in the H2Oil study (Supplemen-
tary Figure S1). In a randomly selected subset of 400 women, pain
during HSG was recorded (199 women in the oil group versus 201
women in the water group). Baseline characteristics of this subset are
shown in Table II.
Table III shows the number of women with an ongoing pregnancy in
the oil versus water group categorised per pain score.
The overall median pain score was 5.0 (IQR 3.0–6.8), 4.8 (IQR 3.0–
6.4) in the oil group versus 5.0 (IQR 3.0–6.7) in the water group (P-































Logistic regression analysis indicated a significant interaction between
HSG with the use of oil-based contrast, ongoing pregnancy and pain
during HSG (P-value 0.047). In women who scored pain during HSG
as a VAS of 6 or more, ongoing pregnancy rates during HSG with oil
contrast were found to be significantly higher compared to HSG with
water contrast (oil group versus water group RR, 1.7; 95% CI, 1.1–2.5),
while in women with a pain score of 5 or less, there was no difference
in ongoing pregnancy rates between the use of oil- or water-based
contrast (RR, 0.99; 95% CI, 0.66–1.5).
In both groups, 91% of the women had a normal HSG with bilateral
patent tubes. In 169 women with a VAS of 6 or higher, 13 had an
abnormal or inconclusive HSG and underwent a diagnostic laparoscopy
in the first 6 months following HSG (six in the oil group versus seven
in the water group); of these, two women had endometriosis ASRM
Table II Baseline characteristics of women within the pain score subset.
Oil-based contrast (n = 199) Water-based contrast (n = 201)
......................................................................................................................................................
Age (years) 33.9 (31.3–36.6) 33.7 (31.6–36.4)
BMIa (kg/m2) 22.2 (20.6–24.6) 22.4 (20.9–24.9)
Duration of infertility (months) 19.2 (16.0–25.7) 19.8 (15.7–26.9)
Cycle duration (days) 28.0 (27.0–30.0) 28.0 (27.0–30.0)
Ethnicityb
- Caucasian 168 (84.4) 157 (78.1)
- Non-Caucasian 26 (13.1) 39 (19.4)
- Unknown 5 (2.5) 5 (2.5)
Smokingc 19 (9.5) 30 (14.9)
Previous large loop excision of the transformation
zone or conisation of the cervix
9 (4.5) 6 (3.0)
Previous myoma or polyp resection or cystectomy 0 (0.0) 1 (0.5)
Previous tubal surgery 0 (0.0) 0 (0.0)
Previous intestinal surgery 10 (5.0) 14 (7.0)
Primary infertility 135 (67.8) 139 (69.2)
Total motile sperm count (million/ml) 75.4 (28.2–174.7) 71.8 (28.5–126.8)
Data presented as median (IQR) or number of women (%).
aThe body-mass index is the weight in kilograms divided by the square of the height in meters.
bEthnicity was reported by the clinicians.
cData on maternal smoking were missing for 10 women in the oil group and 8 women in the water group.
Table III Ongoing pregnancies (%) after the use of oil- and water-based contrast during HSG









0–2 7/19 (36.8) 3/17 (17.6) 1.8 (0.5–6.1)
2–4 12/55 (21.8) 12/47 (25.5) 0.9 (0.4–1.8)
4–6 19/52 (36.5) 22/59 (37.3) 1.0 (0.6–1.7)
6–8 27/58 (46.6) 17/58 (29.3) 1.4 (0.8–2.4)
8–10 9/15 (60.0) 5/20 (25.0) 1.9 (0.7–4.8)
≤5.0 34/118 (28.8) 33/113 (29.2) 0.99 (0.66–1.5)
≥6.0 40/81 (49.4) 26/88 (29.6) 1.7 (1.1–2.5)
Data presented as number of women (%).
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Table IV Ongoing pregnancies (%) after the use of oil- and water-based contrast during HSG









<5 mL 12/36 (33.3) 9/38 (23.7) 1.3 (0.6–2.8)
5–10 ml 40/107 (37.4) 28/106 (26.4) 1.3 (0.9–2.0)
10–15 mL 21/49 (42.9) 13/51 (25.5) 1.5 (0.8–2.7)
15–20 mL 5/17 (29.4) 4/9 (44.4) 0.7 (0.2–2.3)
20–25 mL 19/42 (45.2) 8/45 (17.8) 2.1 (0.99–4.3)
25–30 mL 1/2 (50.0) 0/2 (0.0) 2.3 (0.1–38.1)
30–35 mL 0/0 (0.0) 1/4 (25.0) 2.0 (0.2–22.1)
>35 ml 1/1 (100.0) 0/2 (0.0) 3.0 (0.2–48.0)
≤8.3 ml 45/123 (36.6) 36/133 (27.1) 1.4 (0.9–1.9)
>8.3 ml 54/132 (40.9) 27/124 (21.8) 1.9 (1.3–2.8)
Data presented as number of women (%).
grade 2–3 diagnosed (one in the oil group versus one in the water
group). Also, in 231 women with a VAS score of 5 or lower, 13
underwent a diagnostic laparoscopy in the first 6 months following
HSG, which resulted for five women in the diagnosis endometriosis
ASRM grade 1–4 (three in the oil group versus two in the water
group).
Volume of used contrast medium during HSG was recorded in
a randomly selected subset of 512 women, 255 women in the oil
group versus 257 women in the water group, respectively. Baseline
characteristics of this subset of women are shown in Supplementary
Table I.
Table IV shows the number of women with an ongoing pregnancy
in the oil versus water group categorised per volume of contrast.
The overall median of used contrast volume was 8.3 ml (IQR
5.8–14.0), 9.0 ml (IQR 5.7–15.0) in the oil group versus 8.0 ml
(IQR 5.9–13.0) in the water group (P-value 0.72), with a median
split for the whole population of 8.3 ml. A logistic regression
analysis showed no interaction between types of contrast used




In this post-hoc analysis of the multicentre randomised controlled
H2Oil study, we found that the treatment effect of oil-based
contrast during HSG only occurred in those women who expe-
rienced pain during HSG. In women with pain scores of 6 and
higher, HSG with oil contrast significantly increased the 6-month
ongoing pregnancy rate from 30% to almost 50% as compared
to the use of water contrast (RR 1.7; 95% CI, 1.1–2.5), while
in women with a pain score of 5 or lower, there was no effect
of oil contrast compared to water contrast (6-month ongoing
pregnancy rate 30% versus 30%, RR, 1.0; 95% CI, 0.7–1.5). The




















































































This study is based on data of a large robust RCT. For this post-
hoc analysis, we used a subset of randomly selected women in which
pain scores and volume of used contrast prospectively were reported
and measured. Randomisation was also successful within the subsets
of women. Pain scores and volume of used contrast were registered
prospectively at the day of HSG independent of any knowledge of the
outcomes.
Our study also has limitations. We studied a subset of women
from the original H2Oil study, as not every woman had a pain score
and/or used volume of contrast measured. No formal power analyses
were performed for these post-hoc analyses. This trial was limited to
infertile women younger than 39 years of age, with a spontaneous
ovulatory cycle and with a low risk for tubal pathology. Consequently,
our findings cannot be generalised to infertile women who do not share
these features. While additional treatments were allowed, the number
of women who underwent artificial reproductive technologies were
similar in the both groups. As this analysis was post-hoc and not pre-
specified, our findings should be regarded exploratory and validated in
future studies.
In this study, only one type of oil-based contrast and one type of
water-based contrast were used to create two homogenous groups,
which mirrored daily Dutch practice. However, it is questionable
whether these findings are generalisable for other types of contrasts.
This study was not a blinded trial, as pain scores were recorded
immediately after completion of the HSG procedure and volume
of contrast was documented by the doctor who administered the
contrast. However, we render it unlikely that any of the participating
women or the doctors were aware of a possible effect of pain or
volume, and our primary endpoint, ongoing pregnancy, was objective,
which makes it unlikely that a lack of blinding influenced our findings.
The use of pain medication depended on the local protocol of the
participating hospitals and was not registered. Furthermore, it has been
suggested that the pre-procedural anxiety level affects pain scores in
women undergoing HSG (Tokmak et al., 2015). As we did not report
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Furthermore, the type of HSG technique used (Semm Cup, metal
cannula (hysterophore) or balloon catheter) depended on preference
and/or experience of the performing gynaecologist. A few small
studies have reported less pain during HSG with the use of a balloon
catheter, as compared to a metal cannula or cervical cup; however, the
differences have been minimal (Tur-Kaspa et al., 1998; Cohen et al.,
2001; Ricci et al., 2007). In our study, the numbers of used techniques
were comparable between the two groups and within the pain subset;
however, the technique could possible influence pain scores. Finally,
it has been suggested that pre-warmed contrast medium (to 37◦C)
compared to contrast medium at room temperature alleviates the
pain associated with HSG (Zhu et al., 2012). In this study, the use of
pre-warmed contrast depended on the local protocol; this might have
impacted the pain scores in this study.
Implications
As mentioned earlier, several potential theories have been suggested
to clarify the fertility-enhancing mechanism of tubal flushing, espe-
cially with the use of oil-based contrast. Independent of the type
of contrast, tubal flushing itself has a treatment effect in women
undergoing tubal assessment (Dreyer et al., 2019; Wang et al., 2019).
An immunobiological effect of oil-based contrast on endometrium
receptivity with enhanced implantation has been suggested (Yun and
Lee, 2004; Johnson, 2005; Johnson, 2014). Another possible expla-
nation is modulation of peritoneal macrophage activity by oil-based
contrast, resulting in alteration of cytokine production, inhibition of
sperm phagocytosis and maturation of dendritic cells and regulatory
T cells in the peritoneal cavity (Sawatari et al., 1993; Mikulska et al.,
1994; Izumi et al., 2017). Other proposed explanations are stimulation
of ciliary activity in the tubes, improvement of cervical mucus and
iodine-induced bacteriostatic action on mucus membranes (Soules and
Spadoni, 1982; Mohiyiddeen et al., 2015).
Also, oil-based contrast is derived from poppy seed oil, which con-
tains opium alkaloids. Recent research demonstrated that receptors
for these opioids are present and expressed in human endometrial cells
during the menstrual cycle showing that the opioid receptor expression
changes during the menstrual cycle: its mRNA expression increased
during the proliferative phase and decreased during the secretory
phase of the menstrual cycle with maximum values around the time of
ovulation (Totorikaguena et al., 2017). The cyclic upregulation of the
opioid receptor, especially during the period from the mid-proliferative
to the mid-secretory phase of the menstrual, suggests a role in implan-
tation and could explain, at least in part, for the aforementioned
increased pregnancy rates after use of oil-based contrast.
The association found between pain and treatment effect of oil-
based contrast during HSG on ongoing pregnancy might be explained
by a higher intrauterine pressure induced by mucus plugs or debris
in the proximal part of the tubes. By flushing the fallopian tubes,
pregnancy-hindering mucus plugs or debris might be dislodged and
flushed away from otherwise undamaged fallopian tubes, therefore,
enhancing fertility. The higher intrauterine pressure associated with the
dislodgement of mucus plugs and debris might cause more pain. The
existence of obstructive debris in the proximal parts of the tube was
confirmed in 1992 by using falloposcopy and found to histologically
consist of casts of debris containing aggregates of histiocyte-like cells
probably of endometrial stromal or mesothelial origin (Kerin et al.,





























































































































be washed away by hydro-dissection. However, falloposcopy may
under-diagnose the occurrence of obstructive debris because of easily
mobilised debris, which is washed away before the falloposcope is in
place (Kerin et al., 1992). As shown in Table I, there are multiple differ-
ences between the chemical and physical characteristics of oil-based
and water-based contrast. Oil-based contrast has a lower viscosity
and higher iodine concentration as compared to water-based contrast.
There is currently very limited evidence regarding the impact of these
characteristics, although these differences in chemical and physical
characteristics of both contrast media will most probably contribute
to the observed treatment effect. Future studies are needed.
Two previous oil-water studies addressed interaction with pain at
HSG (Alper et al., 1986; Lindequist et al., 1994). One study found, in
131 women, comparable pain scores in the oil group versus the water
group, respectively, mean 2.9 (SD 0.9) versus 3.2 (SD 1.6), and found
no clear correlation between volume of contrast administered or cycle
day and pain score (Alper et al., 1986). Another study reported that
98 of the 245 women (40%) experienced moderate to severe pain
during HSG, independent of the contrast medium used; however, they
did not link this to ongoing pregnancy (Lindequist et al., 1994). None
of the other oil-water RCTs explored any potential associations or
interactions with the treatment effect (de Boer et al., 1988; Rasmussen
et al., 1991; Spring et al., 2000).
Finally, venous intravasation occurs in ∼2–7% of the HSGs, which can
be painful for women (Bateman et al., 1980; Nunley et al., 1987; Dusak
et al., 2013). No cases of venous intravasation were reported in our
H2Oil study, and serious adverse events related to the HSG procedure
did not occur in >1100 randomised women, indicating that none of the
possible missed cases of intravasation was symptomatic or had clinical
consequences (Dreyer et al., 2017). Since the prevalence of more
severe pain was much higher than the prevalence of intravasation, the
higher pregnancy rates observed in the women with a pain score of ≥6
are not related to venous intravasation of the oil-based contrast.
Future, preferably in vitro, studies to confirm the association of pain
during tubal flushing and treatment effect and thereby the underlying
fertility-enhancing mechanism of tubal flushing with oil contrast are
welcome.
Conclusion
Moderate to severe pain during HSG with the use of oil-based contrast
is associated with more pregnancies compared to the use of water-
based contrast (6-month ongoing pregnancy rate 49.4% versus 29.6%,
RR 1.7; 95% CI, 1.1–2.5), whereas in women who reported mild or
no pain (pain score of 5 or lower), no difference in pregnancies was
found between the use of oil- or water-based contrast (RR 0.99; 95%
CI, 0.66–1.5).
Supplementary data
Supplementary data are available at Human Reproduction online.
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